Global Self-monitoring Blood Glucose Devices Market 2015-2019 with Abbott Laboratories, Arkray, Bayer Healthcare, LifeScan & Roche Diagnostics

News provided by

Jan 04, 2016, 01:10 ET

DUBLIN, Jan. 4, 2015 /PRNewswire/ --

Research and Markets(http://www.researchandmarkets.com/research/jmxjbs/global) has announced the addition of the "Global Self-monitoring Blood Glucose Devices Market 2015-2019" report to their offering.

The global self-monitoring blood glucose devices market to grow at a CAGR of 10.47% over the period 2014-2019.

Global Self-monitoring Blood Glucose Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Self-monitoring blood glucose device is a home-based electronic device. It consists of a glucose sensor and a transmitter that transmits information about glucose levels through radiowaves from the sensor to a receiver, where it is displayed. The regular usage of self-monitoring blood glucose devices can improve self-management of diabetes and prompt an individual to undergo proper diabetes treatment.

Though diabetes is a chronic metabolic condition, it can be controlled with proper medication, and dietary and lifestyle management. Most people prefer SMBG devices for convenient monitoring of blood glucose levels. Moreover, regular blood glucose testing is the cornerstone of effective diabetes management. Usage of blood glucose test strips and meters at home can help patients obtain an accurate blood glucose level reading within few seconds. This trend is anticipated to have a significant impact on the SMBG devices market.

According to the report, according to WHO, the number of people aged 60 and above will increase tremendously by 2050. By 2030, more than 22% of the world's population will be over 65 years. Almost one-third of the elderly people over the age of 65 are affected by diabetes. The Americas is reported to have a high elderly population, which is estimated to grow at a minimal rate by 2050. Similarly, in Europe, the elderly population will increase by 2050 because of an increase in life expectancy and advances in the healthcare industry. The percentage of the elderly population in APAC is low, including China and India. However, the region will have the largest aging population by 2050.

Further, the report states that the presence of alternative methods of glucose monitoring could hinder the growth of the SMBG devices market.

Key vendors

Abbott Laboratories
Arkray
Bayer Healthcare
LifeScan
Roche Diagnostics

Other prominent vendors

Animas
B. Braun Melsungen
Bionime
Bioptik Technology
Chongqing Haray International Business
Dexcom
Gluco-Ease
LabStyle Innovations
Integrity Applications
M Pharmaceutical
Medtronic
Medisana
Nipro Diagnostics
Nova Biomedical
OrSense
Sunrising Enterprise
Tekcapital
Grove Instruments
Wuhan HNC Technology

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: SMBG: An overview

Part 06: Incidence and prevalence

Part 07: Market landscape

Part 08: Market segmentation by type of SMBG components

Part 09: Geographical segmentation

Part 10: Market drivers

Part 11: Impact of drivers

Part 12: Market challenges

Part 13: Impact of drivers and challenges

Part 14: Market trends

Part 15: Vendor landscape

Part 16: Key Vendor Analysis

Part 17: Appendix

For more information visit http://www.researchandmarkets.com/research/jmxjbs/global